AJMC Staff

Black populations suffered 1.6 million excess deaths in the past 20 years, new studies find; the Federal Trade Commission (FTC) sues to block Amgen from acquiring Horizon Therapeutics, citing 2 drugs that have no competition; cancer drug shortages are approaching an all-time high.

WHO urges caution regarding artificial intelligence (AI) bias; South Carolina ban would restrict abortion at 6 weeks; appeals court pauses ruling barring free preventative health services.

UnitedHealthcare will require most colonoscopies to have prior authorization; the World Health Organization says that progress in reducing maternal and infant deaths has halted; hospitals are creating their own police forces to address increasing violence against staff.

It is important to have a multidisciplinary approach in the treatment of patients with small cell lung cancer, according to Jason Porter, MD, medical oncologist and hematologist, West Cancer Center and Research Institute, Memphis, Tennessee. This team approach allows for early intervention with signs of relapse or progression.

The FDAs newest blood donation guidance may expand donation eligibility; Pfizer CEO anticipates lawsuits to stop US drug price plan; drug shortages have worsened and may increase even with the end of the COVID-19 public health emergency.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

The end of the national Public Health Emergency (PHE) also concludes some public support programs; FDA advisers unanimously recommended that the agency should approve OTC birth control pills; insulin manufacturers and pharmacy benefit managers testified on Capitol Hill Wednesday over the cost of the drug.

Florida Cancer Specialists recently released a case study that outlined its role in the evolution of a first-line therapy for adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) that recently received FDA approval.

Biotech company EQRx discards low-cost drug plan, cuts its therapy programs to 1, and slashes staff in “reset”; health care systems’ preparation for new Alzheimer disease drug takes location and resources into consideration; the Drug Enforcement Administration (DEA) will extend telemedicine prescribing for certain controlled medications through at least November 11.

The end of the COVID-19 public health emergency spotlights US outbreak tracking weakness; the American Psychological Association released guidelines to guide teen social media use; the first study funded by the US government to measure safe injection site effectiveness was announced Monday.

The possible consequences for health care if the United States breaches the debt ceiling; skepticism follows proposal for over-the-counter birth control pill; North Carolina governor calls potential abortion ban harmful.

It's not normal to be in so much pain that you miss work several times a month and there are more things payers can do, said Linda D. Bradley, MD, professor of Obstetrics and Gynecology and Reproductive Medicine, Cleveland Clinic.

The Biden administration has come to an agreement with the Alabama Department of Public Health to improve sewer services for residents of Lowndes County who have lived with pools of raw sewage; COVID-19 was still a leading cause of death in 2022; Medicare improperly paid providers for some psychotherapy services during the first year of the COVID-19 public health emergency.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

The DEA desires to extend its COVID-19 prescription flexibilities; the Biden administration warns Americans to avoid medical credit cards; more US women are avoiding unwanted or ill-timed pregnancies, but a growing share of women over 35 say their pregnancies are coming later than desired.

OneOncology now has partner practices in 14 states.

One dose of human papillomavirus vaccine (HPV) vaccine can prevent infection for at least 3 years, and maybe even longer; Eli Lilly plans to seek FDA approval for Alzheimer drug that slows decline; New York governor signed a bill expanding contraceptive access in the state next year.

The partnership will help develop standards for data transfer to eliminate manual steps used in clinical trials.

Democrats look to build on the Inflation Reduction Act, and both parties seem to want to reform the pharmacy benefit manager industry; the US federal government and Gilead Sciences will go to trial this week in a multibillion-dollar dispute; the US Surgeon General warns that loneliness is a public health threat.

A settled class-action lawsuit paves the way for 5 million New Yorkers on Medicaid to have expanded dental coverage; 2 hospitals broke federal law by denying a woman whose life was in danger an abortion; mask mandates in most health care settings are being lifted around the United States.

Jason Porter, MD, medical oncologist and hematologist, West Cancer Center and Research Institute, Memphis, Tennessee, defines small cell lung cancer and the risk factors associated with it. With smoking as a major risk factor, diagnosis for small cell lung cancer is rare compared with non–small cell lung cancer and varies widely by region in the United States.

Optimal care that should be offered to all patients includes not only pain relief but also a complete pelvic exam and a discussion about the many options that are available for fibroids and endometriosis, including minimally invasive, organ-conserving surgery, said Linda D. Bradley, MD, professor of Obstetrics and Gynecology and Reproductive Medicine, Cleveland Clinic.

Results from 2 late-stage trials evaluating generalized myasthenia gravis therapies indicated both drugs, rozanolixizumab and zilucoplan, have potential as targeted treatment options.

The European Union has proposed the biggest drug overhaul in 20 years, prompting industry conflict; CMS has proposed 2 new rules focused on increasing care access and quality of care for people enrolled in Medicaid and the Children’s Health Insurance Program; proposed legislation would promise $6 billion for treatments of drug-resistant infections that win approval.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

The antibody drug conjugate received FDA approval in November 2022.

FDA accelerates approval of drug for amyotrophic lateral sclerosis (ALS); hundreds of thousands could lose Medicaid coverage under Republican debt bill including work requirements; the Department of Veterans Affairs (VA) reports that half a million veterans have filed claims for health benefits related to toxic exposures.

A new rule could provide access to health care for Deferred Action for Childhood Arrivals (DACA) program recipients; North Dakota governor signs law banning most abortions in the state; legislators call on China to cooperate in investigation of COVID-19 origins.

By better understanding the nature of atopic dermatitis and its varying comorbidities, providers might be able to better predict patient outcomes, said Raj Chovatiya, MD, PhD, assistant professor of dermatology, Northwestern University Feinberg School of Medicine.